nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—TAOK1—forebrain—attention deficit hyperactivity disorder	0.0131	0.0187	CbGeAlD
Pazopanib—MAP3K9—midbrain—attention deficit hyperactivity disorder	0.0116	0.0164	CbGeAlD
Pazopanib—SH2B3—cardiovascular system—attention deficit hyperactivity disorder	0.0105	0.0149	CbGeAlD
Pazopanib—FGFR3—forebrain—attention deficit hyperactivity disorder	0.0104	0.0147	CbGeAlD
Pazopanib—MAP3K9—nervous system—attention deficit hyperactivity disorder	0.00951	0.0135	CbGeAlD
Pazopanib—MAP3K9—central nervous system—attention deficit hyperactivity disorder	0.00915	0.013	CbGeAlD
Pazopanib—MAP3K9—cerebellum—attention deficit hyperactivity disorder	0.00895	0.0127	CbGeAlD
Pazopanib—TAOK1—midbrain—attention deficit hyperactivity disorder	0.00868	0.0123	CbGeAlD
Pazopanib—SH2B3—midbrain—attention deficit hyperactivity disorder	0.00817	0.0116	CbGeAlD
Pazopanib—MAP3K9—brain—attention deficit hyperactivity disorder	0.00727	0.0103	CbGeAlD
Pazopanib—FGF1—forebrain—attention deficit hyperactivity disorder	0.00718	0.0102	CbGeAlD
Pazopanib—TAOK1—nervous system—attention deficit hyperactivity disorder	0.00714	0.0101	CbGeAlD
Pazopanib—TAOK1—central nervous system—attention deficit hyperactivity disorder	0.00687	0.00977	CbGeAlD
Pazopanib—FGFR3—midbrain—attention deficit hyperactivity disorder	0.00684	0.00972	CbGeAlD
Pazopanib—RIOK2—midbrain—attention deficit hyperactivity disorder	0.00684	0.00972	CbGeAlD
Pazopanib—FLT4—cardiovascular system—attention deficit hyperactivity disorder	0.00684	0.00972	CbGeAlD
Pazopanib—FGFR2—forebrain—attention deficit hyperactivity disorder	0.00678	0.00964	CbGeAlD
Pazopanib—SH2B3—nervous system—attention deficit hyperactivity disorder	0.00672	0.00955	CbGeAlD
Pazopanib—TAOK1—cerebellum—attention deficit hyperactivity disorder	0.00672	0.00954	CbGeAlD
Pazopanib—AURKC—nervous system—attention deficit hyperactivity disorder	0.00662	0.0094	CbGeAlD
Pazopanib—SH2B3—central nervous system—attention deficit hyperactivity disorder	0.00647	0.00919	CbGeAlD
Pazopanib—AURKC—central nervous system—attention deficit hyperactivity disorder	0.00637	0.00905	CbGeAlD
Pazopanib—SH2B3—cerebellum—attention deficit hyperactivity disorder	0.00632	0.00899	CbGeAlD
Pazopanib—EPHB6—forebrain—attention deficit hyperactivity disorder	0.00621	0.00883	CbGeAlD
Pazopanib—FGF1—cardiovascular system—attention deficit hyperactivity disorder	0.00607	0.00863	CbGeAlD
Pazopanib—PI4KB—midbrain—attention deficit hyperactivity disorder	0.00605	0.0086	CbGeAlD
Pazopanib—TAOK3—forebrain—attention deficit hyperactivity disorder	0.00593	0.00842	CbGeAlD
Pazopanib—PDGFRA—forebrain—attention deficit hyperactivity disorder	0.00589	0.00837	CbGeAlD
Pazopanib—FGFR2—cardiovascular system—attention deficit hyperactivity disorder	0.00574	0.00815	CbGeAlD
Pazopanib—STK16—nervous system—attention deficit hyperactivity disorder	0.00571	0.00812	CbGeAlD
Pazopanib—LYN—nervous system—attention deficit hyperactivity disorder	0.00565	0.00803	CbGeAlD
Pazopanib—RIOK2—nervous system—attention deficit hyperactivity disorder	0.00562	0.00799	CbGeAlD
Pazopanib—FGFR3—nervous system—attention deficit hyperactivity disorder	0.00562	0.00799	CbGeAlD
Pazopanib—BMPR1B—nervous system—attention deficit hyperactivity disorder	0.00557	0.00791	CbGeAlD
Pazopanib—MAP3K19—nervous system—attention deficit hyperactivity disorder	0.00557	0.00791	CbGeAlD
Pazopanib—STK16—central nervous system—attention deficit hyperactivity disorder	0.0055	0.00782	CbGeAlD
Pazopanib—TAOK1—brain—attention deficit hyperactivity disorder	0.00546	0.00775	CbGeAlD
Pazopanib—LYN—central nervous system—attention deficit hyperactivity disorder	0.00544	0.00774	CbGeAlD
Pazopanib—FGFR3—central nervous system—attention deficit hyperactivity disorder	0.00542	0.0077	CbGeAlD
Pazopanib—RIOK2—central nervous system—attention deficit hyperactivity disorder	0.00542	0.0077	CbGeAlD
Pazopanib—STK16—cerebellum—attention deficit hyperactivity disorder	0.00538	0.00764	CbGeAlD
Pazopanib—MAP3K19—central nervous system—attention deficit hyperactivity disorder	0.00536	0.00762	CbGeAlD
Pazopanib—BMPR1B—central nervous system—attention deficit hyperactivity disorder	0.00536	0.00762	CbGeAlD
Pazopanib—FLT1—cardiovascular system—attention deficit hyperactivity disorder	0.00532	0.00755	CbGeAlD
Pazopanib—KDR—forebrain—attention deficit hyperactivity disorder	0.00531	0.00755	CbGeAlD
Pazopanib—PIP4K2C—midbrain—attention deficit hyperactivity disorder	0.00531	0.00755	CbGeAlD
Pazopanib—FGFR3—cerebellum—attention deficit hyperactivity disorder	0.00529	0.00752	CbGeAlD
Pazopanib—RIOK2—cerebellum—attention deficit hyperactivity disorder	0.00529	0.00752	CbGeAlD
Pazopanib—FGFR1—midbrain—attention deficit hyperactivity disorder	0.00527	0.00749	CbGeAlD
Pazopanib—BMPR1B—cerebellum—attention deficit hyperactivity disorder	0.00524	0.00745	CbGeAlD
Pazopanib—CSF1R—forebrain—attention deficit hyperactivity disorder	0.00519	0.00737	CbGeAlD
Pazopanib—SH2B3—brain—attention deficit hyperactivity disorder	0.00514	0.0073	CbGeAlD
Pazopanib—AURKC—brain—attention deficit hyperactivity disorder	0.00506	0.00719	CbGeAlD
Pazopanib—STK36—nervous system—attention deficit hyperactivity disorder	0.00505	0.00718	CbGeAlD
Pazopanib—STK10—cardiovascular system—attention deficit hyperactivity disorder	0.00503	0.00715	CbGeAlD
Pazopanib—TAOK3—cardiovascular system—attention deficit hyperactivity disorder	0.00501	0.00712	CbGeAlD
Pazopanib—PDGFRA—cardiovascular system—attention deficit hyperactivity disorder	0.00498	0.00708	CbGeAlD
Pazopanib—PI4KB—nervous system—attention deficit hyperactivity disorder	0.00498	0.00707	CbGeAlD
Pazopanib—LIMK2—nervous system—attention deficit hyperactivity disorder	0.00488	0.00694	CbGeAlD
Pazopanib—STK36—central nervous system—attention deficit hyperactivity disorder	0.00486	0.00691	CbGeAlD
Pazopanib—PI4KB—central nervous system—attention deficit hyperactivity disorder	0.00479	0.00681	CbGeAlD
Pazopanib—STK36—cerebellum—attention deficit hyperactivity disorder	0.00475	0.00676	CbGeAlD
Pazopanib—FGF1—midbrain—attention deficit hyperactivity disorder	0.00474	0.00674	CbGeAlD
Pazopanib—LIMK2—central nervous system—attention deficit hyperactivity disorder	0.0047	0.00668	CbGeAlD
Pazopanib—PI4KB—cerebellum—attention deficit hyperactivity disorder	0.00468	0.00665	CbGeAlD
Pazopanib—PLK4—brain—attention deficit hyperactivity disorder	0.00462	0.00657	CbGeAlD
Pazopanib—LIMK2—cerebellum—attention deficit hyperactivity disorder	0.0046	0.00653	CbGeAlD
Pazopanib—KDR—cardiovascular system—attention deficit hyperactivity disorder	0.00449	0.00639	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—attention deficit hyperactivity disorder	0.00449	0.00639	CbGeAlD
Pazopanib—CSF1R—cardiovascular system—attention deficit hyperactivity disorder	0.00439	0.00623	CbGeAlD
Pazopanib—STK16—brain—attention deficit hyperactivity disorder	0.00437	0.00621	CbGeAlD
Pazopanib—PIP4K2C—nervous system—attention deficit hyperactivity disorder	0.00437	0.0062	CbGeAlD
Pazopanib—LYN—brain—attention deficit hyperactivity disorder	0.00432	0.00614	CbGeAlD
Pazopanib—FGFR3—brain—attention deficit hyperactivity disorder	0.0043	0.00611	CbGeAlD
Pazopanib—RIOK2—brain—attention deficit hyperactivity disorder	0.0043	0.00611	CbGeAlD
Pazopanib—MAP3K19—brain—attention deficit hyperactivity disorder	0.00426	0.00605	CbGeAlD
Pazopanib—BMPR1B—brain—attention deficit hyperactivity disorder	0.00426	0.00605	CbGeAlD
Pazopanib—PIP4K2C—central nervous system—attention deficit hyperactivity disorder	0.0042	0.00597	CbGeAlD
Pazopanib—FLT1—midbrain—attention deficit hyperactivity disorder	0.00415	0.0059	CbGeAlD
Pazopanib—MAP3K2—nervous system—attention deficit hyperactivity disorder	0.00414	0.00588	CbGeAlD
Pazopanib—PIP4K2C—cerebellum—attention deficit hyperactivity disorder	0.00411	0.00584	CbGeAlD
Pazopanib—EPHB6—midbrain—attention deficit hyperactivity disorder	0.0041	0.00583	CbGeAlD
Pazopanib—FGFR1—cerebellum—attention deficit hyperactivity disorder	0.00407	0.00579	CbGeAlD
Pazopanib—MAP3K2—central nervous system—attention deficit hyperactivity disorder	0.00398	0.00566	CbGeAlD
Pazopanib—KIT—cardiovascular system—attention deficit hyperactivity disorder	0.00398	0.00566	CbGeAlD
Pazopanib—TAOK3—midbrain—attention deficit hyperactivity disorder	0.00391	0.00556	CbGeAlD
Pazopanib—FGF1—nervous system—attention deficit hyperactivity disorder	0.0039	0.00554	CbGeAlD
Pazopanib—MAP3K2—cerebellum—attention deficit hyperactivity disorder	0.00389	0.00553	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—attention deficit hyperactivity disorder	0.00389	0.00553	CbGeAlD
Pazopanib—STK36—brain—attention deficit hyperactivity disorder	0.00386	0.00549	CbGeAlD
Pazopanib—PI4KB—brain—attention deficit hyperactivity disorder	0.0038	0.0054	CbGeAlD
Pazopanib—FGF1—central nervous system—attention deficit hyperactivity disorder	0.00375	0.00533	CbGeAlD
Pazopanib—LIMK2—brain—attention deficit hyperactivity disorder	0.00373	0.00531	CbGeAlD
Pazopanib—FGFR2—nervous system—attention deficit hyperactivity disorder	0.00368	0.00523	CbGeAlD
Pazopanib—FGF1—cerebellum—attention deficit hyperactivity disorder	0.00367	0.00521	CbGeAlD
Pazopanib—FGFR2—central nervous system—attention deficit hyperactivity disorder	0.00354	0.00504	CbGeAlD
Pazopanib—KDR—midbrain—attention deficit hyperactivity disorder	0.00351	0.00499	CbGeAlD
Pazopanib—MAP2K5—midbrain—attention deficit hyperactivity disorder	0.00351	0.00499	CbGeAlD
Pazopanib—FGFR2—cerebellum—attention deficit hyperactivity disorder	0.00346	0.00492	CbGeAlD
Pazopanib—CSF1R—midbrain—attention deficit hyperactivity disorder	0.00342	0.00487	CbGeAlD
Pazopanib—FLT1—nervous system—attention deficit hyperactivity disorder	0.00341	0.00485	CbGeAlD
Pazopanib—EPHB6—nervous system—attention deficit hyperactivity disorder	0.00337	0.00479	CbGeAlD
Pazopanib—FLT4—brain—attention deficit hyperactivity disorder	0.00335	0.00477	CbGeAlD
Pazopanib—PIP4K2C—brain—attention deficit hyperactivity disorder	0.00334	0.00474	CbGeAlD
Pazopanib—FGFR1—brain—attention deficit hyperactivity disorder	0.00331	0.0047	CbGeAlD
Pazopanib—FLT1—central nervous system—attention deficit hyperactivity disorder	0.00329	0.00467	CbGeAlD
Pazopanib—EPHB6—central nervous system—attention deficit hyperactivity disorder	0.00325	0.00462	CbGeAlD
Pazopanib—STK10—nervous system—attention deficit hyperactivity disorder	0.00323	0.00459	CbGeAlD
Pazopanib—TAOK3—nervous system—attention deficit hyperactivity disorder	0.00322	0.00457	CbGeAlD
Pazopanib—FLT1—cerebellum—attention deficit hyperactivity disorder	0.00321	0.00456	CbGeAlD
Pazopanib—PDGFRA—nervous system—attention deficit hyperactivity disorder	0.0032	0.00454	CbGeAlD
Pazopanib—EPHB6—cerebellum—attention deficit hyperactivity disorder	0.00317	0.00451	CbGeAlD
Pazopanib—MAP3K2—brain—attention deficit hyperactivity disorder	0.00316	0.00449	CbGeAlD
Pazopanib—STK10—central nervous system—attention deficit hyperactivity disorder	0.00311	0.00442	CbGeAlD
Pazopanib—KIT—midbrain—attention deficit hyperactivity disorder	0.00311	0.00442	CbGeAlD
Pazopanib—TAOK3—central nervous system—attention deficit hyperactivity disorder	0.0031	0.0044	CbGeAlD
Pazopanib—PDGFRA—central nervous system—attention deficit hyperactivity disorder	0.00308	0.00438	CbGeAlD
Pazopanib—STK10—cerebellum—attention deficit hyperactivity disorder	0.00304	0.00432	CbGeAlD
Pazopanib—PDGFRB—midbrain—attention deficit hyperactivity disorder	0.00304	0.00432	CbGeAlD
Pazopanib—TAOK3—cerebellum—attention deficit hyperactivity disorder	0.00303	0.0043	CbGeAlD
Pazopanib—PDGFRA—cerebellum—attention deficit hyperactivity disorder	0.00301	0.00428	CbGeAlD
Pazopanib—FGF1—brain—attention deficit hyperactivity disorder	0.00298	0.00423	CbGeAlD
Pazopanib—KDR—nervous system—attention deficit hyperactivity disorder	0.00288	0.0041	CbGeAlD
Pazopanib—MAP2K5—nervous system—attention deficit hyperactivity disorder	0.00288	0.0041	CbGeAlD
Pazopanib—CSF1R—nervous system—attention deficit hyperactivity disorder	0.00282	0.004	CbGeAlD
Pazopanib—FGFR2—brain—attention deficit hyperactivity disorder	0.00281	0.004	CbGeAlD
Pazopanib—KDR—central nervous system—attention deficit hyperactivity disorder	0.00278	0.00395	CbGeAlD
Pazopanib—MAP2K5—central nervous system—attention deficit hyperactivity disorder	0.00278	0.00395	CbGeAlD
Pazopanib—KDR—cerebellum—attention deficit hyperactivity disorder	0.00271	0.00386	CbGeAlD
Pazopanib—MAP2K5—cerebellum—attention deficit hyperactivity disorder	0.00271	0.00386	CbGeAlD
Pazopanib—CSF1R—central nervous system—attention deficit hyperactivity disorder	0.00271	0.00385	CbGeAlD
Pazopanib—CSF1R—cerebellum—attention deficit hyperactivity disorder	0.00265	0.00377	CbGeAlD
Pazopanib—FLT1—brain—attention deficit hyperactivity disorder	0.00261	0.00371	CbGeAlD
Pazopanib—EPHB6—brain—attention deficit hyperactivity disorder	0.00258	0.00366	CbGeAlD
Pazopanib—KIT—nervous system—attention deficit hyperactivity disorder	0.00256	0.00363	CbGeAlD
Pazopanib—PDGFRB—nervous system—attention deficit hyperactivity disorder	0.0025	0.00355	CbGeAlD
Pazopanib—STK10—brain—attention deficit hyperactivity disorder	0.00247	0.00351	CbGeAlD
Pazopanib—KIT—central nervous system—attention deficit hyperactivity disorder	0.00246	0.0035	CbGeAlD
Pazopanib—TAOK3—brain—attention deficit hyperactivity disorder	0.00246	0.0035	CbGeAlD
Pazopanib—PDGFRA—brain—attention deficit hyperactivity disorder	0.00244	0.00347	CbGeAlD
Pazopanib—KIT—cerebellum—attention deficit hyperactivity disorder	0.00241	0.00342	CbGeAlD
Pazopanib—PDGFRB—central nervous system—attention deficit hyperactivity disorder	0.0024	0.00342	CbGeAlD
Pazopanib—PDGFRB—cerebellum—attention deficit hyperactivity disorder	0.00235	0.00334	CbGeAlD
Pazopanib—MAP2K5—brain—attention deficit hyperactivity disorder	0.00221	0.00313	CbGeAlD
Pazopanib—KDR—brain—attention deficit hyperactivity disorder	0.00221	0.00313	CbGeAlD
Pazopanib—CSF1R—brain—attention deficit hyperactivity disorder	0.00215	0.00306	CbGeAlD
Pazopanib—KIT—brain—attention deficit hyperactivity disorder	0.00195	0.00278	CbGeAlD
Pazopanib—PDGFRB—brain—attention deficit hyperactivity disorder	0.00191	0.00271	CbGeAlD
Pazopanib—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00177	0.00252	CbGeAlD
Pazopanib—ABCG2—midbrain—attention deficit hyperactivity disorder	0.00171	0.00243	CbGeAlD
Pazopanib—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.00132	0.00188	CbGeAlD
Pazopanib—ABCB1—forebrain—attention deficit hyperactivity disorder	0.00127	0.00181	CbGeAlD
Pazopanib—CYP2C8—brain—attention deficit hyperactivity disorder	0.0011	0.00157	CbGeAlD
Pazopanib—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00108	0.00153	CbGeAlD
Pazopanib—ABCG2—brain—attention deficit hyperactivity disorder	0.00107	0.00152	CbGeAlD
Pazopanib—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000978	0.00139	CbGeAlD
Pazopanib—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000962	0.00137	CbGeAlD
Pazopanib—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000941	0.00134	CbGeAlD
Pazopanib—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000926	0.00132	CbGeAlD
Pazopanib—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000905	0.00129	CbGeAlD
Pazopanib—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000842	0.0012	CbGeAlD
Pazopanib—CYP2D6—brain—attention deficit hyperactivity disorder	0.000735	0.00105	CbGeAlD
Pazopanib—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000692	0.000983	CbGeAlD
Pazopanib—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000666	0.000947	CbGeAlD
Pazopanib—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000651	0.000925	CbGeAlD
Pazopanib—ABCB1—brain—attention deficit hyperactivity disorder	0.000529	0.000752	CbGeAlD
Pazopanib—FGFR1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000208	0.000704	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000208	0.000702	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	0.000207	0.000699	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000204	0.00069	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000204	0.000688	CbGpPWpGaD
Pazopanib—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000202	0.00068	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000202	0.00068	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000197	0.000666	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000197	0.000665	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000196	0.000663	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000192	0.000648	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000191	0.000645	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000188	0.000633	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000187	0.000632	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000187	0.000632	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000187	0.000632	CbGpPWpGaD
Pazopanib—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000187	0.00063	CbGpPWpGaD
Pazopanib—CYP1A2—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000186	0.000629	CbGpPWpGaD
Pazopanib—CYP1A2—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000185	0.000625	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000184	0.00062	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000183	0.000619	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000183	0.000618	CbGpPWpGaD
Pazopanib—FGFR2—Disease—SNAP25—attention deficit hyperactivity disorder	0.00018	0.000607	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00018	0.000607	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000179	0.000603	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000178	0.0006	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000177	0.000599	CbGpPWpGaD
Pazopanib—KIT—Disease—SNAP25—attention deficit hyperactivity disorder	0.000177	0.000596	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000176	0.000594	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000174	0.000589	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000172	0.000581	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000172	0.000579	CbGpPWpGaD
Pazopanib—FGFR1—Disease—SNAP25—attention deficit hyperactivity disorder	0.000168	0.000566	CbGpPWpGaD
Pazopanib—PI4KB—Metabolism—EP300—attention deficit hyperactivity disorder	0.000168	0.000566	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—SNAP25—attention deficit hyperactivity disorder	0.000167	0.000564	CbGpPWpGaD
Pazopanib—SH2B3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000165	0.000556	CbGpPWpGaD
Pazopanib—ITK—Immune System—EP300—attention deficit hyperactivity disorder	0.000164	0.000554	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000164	0.000553	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000164	0.000553	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00016	0.000541	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00016	0.000539	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000159	0.000535	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000158	0.000534	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000156	0.000526	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000156	0.000526	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000155	0.000523	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000155	0.000522	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000154	0.00052	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000153	0.000518	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000152	0.000514	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000152	0.000514	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000152	0.000513	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—SNAP25—attention deficit hyperactivity disorder	0.000151	0.000509	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00015	0.000507	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00015	0.000506	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000147	0.000498	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000147	0.000498	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000147	0.000497	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000145	0.000489	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000145	0.000489	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000145	0.000488	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000145	0.000488	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000145	0.000488	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000144	0.000486	CbGpPWpGaD
Pazopanib—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000144	0.000485	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000143	0.000484	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000143	0.000483	CbGpPWpGaD
Pazopanib—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000143	0.000482	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000142	0.00048	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00014	0.000472	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000136	0.000457	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000133	0.00045	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000133	0.000449	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000133	0.000447	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000133	0.000447	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000132	0.000446	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000131	0.000443	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00013	0.00044	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00013	0.000438	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000127	0.000429	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000126	0.000426	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000126	0.000425	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000126	0.000425	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000124	0.000418	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000123	0.000414	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000123	0.000414	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000122	0.000412	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000121	0.000409	CbGpPWpGaD
Pazopanib—LCK—Disease—SNAP25—attention deficit hyperactivity disorder	0.000121	0.000408	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000121	0.000407	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.00012	0.000405	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00012	0.000404	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000118	0.0004	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000118	0.000398	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000117	0.000396	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000117	0.000395	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000116	0.000393	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000116	0.00039	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000115	0.000387	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000114	0.000386	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000114	0.000384	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000114	0.000383	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000113	0.000383	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000112	0.000379	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000112	0.000379	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000112	0.000377	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000111	0.000376	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000111	0.000375	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00011	0.000373	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00011	0.000372	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.00011	0.000372	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.00011	0.000372	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.00011	0.000371	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000109	0.000367	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000108	0.000366	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000107	0.00036	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000106	0.000358	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000106	0.000356	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000104	0.000353	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000104	0.000352	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000103	0.000349	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000103	0.000347	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000103	0.000346	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000102	0.000345	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000101	0.000342	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—EP300—attention deficit hyperactivity disorder	0.000101	0.000341	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—EP300—attention deficit hyperactivity disorder	0.000101	0.000341	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000101	0.000341	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000101	0.00034	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.0001	0.000339	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.0001	0.000339	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0001	0.000338	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.92e-05	0.000335	CbGpPWpGaD
Pazopanib—LYN—Hemostasis—EP300—attention deficit hyperactivity disorder	9.9e-05	0.000334	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	9.83e-05	0.000332	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.81e-05	0.000331	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.79e-05	0.00033	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	9.71e-05	0.000328	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.61e-05	0.000324	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.34e-05	0.000315	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.34e-05	0.000315	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	9.27e-05	0.000313	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.24e-05	0.000312	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—EP300—attention deficit hyperactivity disorder	9.21e-05	0.000311	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	9.11e-05	0.000307	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—EP300—attention deficit hyperactivity disorder	9.11e-05	0.000307	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	9.06e-05	0.000306	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	9.05e-05	0.000305	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—EP300—attention deficit hyperactivity disorder	8.92e-05	0.000301	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—COMT—attention deficit hyperactivity disorder	8.76e-05	0.000296	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.7e-05	0.000294	CbGpPWpGaD
Pazopanib—FGFR3—Disease—EP300—attention deficit hyperactivity disorder	8.5e-05	0.000287	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	8.47e-05	0.000286	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	8.2e-05	0.000277	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—EP300—attention deficit hyperactivity disorder	8.12e-05	0.000274	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	8.06e-05	0.000272	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	8.03e-05	0.000271	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.97e-05	0.000269	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	7.96e-05	0.000269	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.79e-05	0.000263	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	7.73e-05	0.000261	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.73e-05	0.000261	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	7.67e-05	0.000259	CbGpPWpGaD
Pazopanib—FGF1—Immune System—EP300—attention deficit hyperactivity disorder	7.65e-05	0.000258	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—TPH2—attention deficit hyperactivity disorder	7.62e-05	0.000257	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.62e-05	0.000257	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.59e-05	0.000256	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—DPYD—attention deficit hyperactivity disorder	7.49e-05	0.000253	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	7.43e-05	0.000251	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	7.42e-05	0.00025	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	7.38e-05	0.000249	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—EP300—attention deficit hyperactivity disorder	7.31e-05	0.000247	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.2e-05	0.000243	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	7.18e-05	0.000242	CbGpPWpGaD
Pazopanib—FGF1—Disease—EP300—attention deficit hyperactivity disorder	7.07e-05	0.000238	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.97e-05	0.000235	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	6.63e-05	0.000224	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.63e-05	0.000224	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	6.53e-05	0.00022	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.47e-05	0.000218	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	6.34e-05	0.000214	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—EP300—attention deficit hyperactivity disorder	6.33e-05	0.000214	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	6.25e-05	0.000211	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	6.25e-05	0.000211	CbGpPWpGaD
Pazopanib—KIT—Immune System—EP300—attention deficit hyperactivity disorder	6.22e-05	0.00021	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	6.15e-05	0.000208	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—SNAP25—attention deficit hyperactivity disorder	6.09e-05	0.000205	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.07e-05	0.000205	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.95e-05	0.000201	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	5.92e-05	0.0002	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EP300—attention deficit hyperactivity disorder	5.9e-05	0.000199	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EP300—attention deficit hyperactivity disorder	5.89e-05	0.000199	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EP300—attention deficit hyperactivity disorder	5.85e-05	0.000197	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.8e-05	0.000196	CbGpPWpGaD
Pazopanib—KIT—Disease—EP300—attention deficit hyperactivity disorder	5.74e-05	0.000194	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	5.72e-05	0.000193	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EP300—attention deficit hyperactivity disorder	5.45e-05	0.000184	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EP300—attention deficit hyperactivity disorder	5.44e-05	0.000183	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.32e-05	0.00018	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EP300—attention deficit hyperactivity disorder	5.3e-05	0.000179	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.3e-05	0.000179	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	5.3e-05	0.000179	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	5.3e-05	0.000179	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	5.21e-05	0.000176	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	5.19e-05	0.000175	CbGpPWpGaD
Pazopanib—LYN—Immune System—EP300—attention deficit hyperactivity disorder	5.19e-05	0.000175	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.19e-05	0.000175	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.05e-05	0.00017	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	5e-05	0.000169	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.95e-05	0.000167	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EP300—attention deficit hyperactivity disorder	4.9e-05	0.000165	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.84e-05	0.000163	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.76e-05	0.000161	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—COMT—attention deficit hyperactivity disorder	4.61e-05	0.000156	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MAOA—attention deficit hyperactivity disorder	4.58e-05	0.000155	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.44e-05	0.00015	CbGpPWpGaD
Pazopanib—LCK—Immune System—EP300—attention deficit hyperactivity disorder	4.26e-05	0.000144	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	4.23e-05	0.000143	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.09e-05	0.000138	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.09e-05	0.000138	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.09e-05	0.000138	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	4.03e-05	0.000136	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.02e-05	0.000136	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EP300—attention deficit hyperactivity disorder	4.02e-05	0.000136	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	4.02e-05	0.000136	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	3.99e-05	0.000135	CbGpPWpGaD
Pazopanib—LCK—Disease—EP300—attention deficit hyperactivity disorder	3.93e-05	0.000133	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.82e-05	0.000129	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.81e-05	0.000128	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	3.79e-05	0.000128	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	3.76e-05	0.000127	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—EP300—attention deficit hyperactivity disorder	3.76e-05	0.000127	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.74e-05	0.000126	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	3.44e-05	0.000116	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.43e-05	0.000116	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EP300—attention deficit hyperactivity disorder	3.36e-05	0.000113	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.27e-05	0.00011	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—COMT—attention deficit hyperactivity disorder	3.21e-05	0.000108	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	3.19e-05	0.000108	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	3.19e-05	0.000108	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.11e-05	0.000105	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	3.09e-05	0.000104	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EP300—attention deficit hyperactivity disorder	2.75e-05	9.29e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.48e-05	8.36e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.46e-05	8.3e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—EP300—attention deficit hyperactivity disorder	1.98e-05	6.68e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	1.72e-05	5.82e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	1.62e-05	5.48e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—EP300—attention deficit hyperactivity disorder	1.38e-05	4.64e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.06e-05	3.58e-05	CbGpPWpGaD
